Hack Andrew A. F. |
Non-Executive Director |
Nuvalent, Inc. (NUVL)
|
2022-11-03 |
$33.50 |
153.6% |
149,253
|
$4,999,976 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-06-02 |
$3.27 |
-56.5% |
95,519
|
$311,958 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-05-26 |
$3.22 |
-55.9% |
265,155
|
$854,175 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-05-23 |
$3.46 |
-59.0% |
215,599
|
$746,437 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-05-18 |
$3.25 |
-56.3% |
350,000
|
$1,137,660 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-04-13 |
$4.05 |
-64.9% |
617,284
|
$2,500,000 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-04-12 |
$4.18 |
-66.0% |
598,086
|
$2,499,880 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2022-02-07 |
$4.42 |
-67.9% |
1,136,363
|
$5,022,724 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2021-12-30 |
$6.15 |
-76.9% |
815,000
|
$5,012,250 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2021-12-29 |
$5.75 |
-75.3% |
875,000
|
$5,031,250 |
Hack Andrew A. F. |
Non-Executive Director |
Nuvalent, Inc. (NUVL)
|
2021-08-02 |
$17.00 |
399.8% |
735,000
|
$12,495,000 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2021-01-12 |
$18.36 |
-92.3% |
250,000
|
$4,590,000 |
Hack Andrew A. F. |
Non-Executive Director |
Atea Pharmaceuticals, Inc. (AVIR)
|
2020-11-03 |
$24.00 |
-84.9% |
250,000
|
$6,000,000 |
Hack Andrew A. F. |
Non-Executive Director |
DYNAVAX TECHNOLOGIES CORP (DVAX)
|
2020-05-27 |
$5.00 |
117.0% |
1,000,000
|
$5,000,000 |
Hack Andrew A. F. |
Non-Executive Director |
Mersana Therapeutics, Inc. (MRSN)
|
2020-04-07 |
$5.99 |
-76.3% |
3,445,667
|
$20,649,463 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
29.1% |
$22,332,777 |
$76,850,773 |